Izokibep, a Novel IL-17A Inhibitor, Demonstrates HiSCR100 Responses in Moderate-to-Severe Hidradenitis Suppurativa: Open-Label Part A Results of a Phase 2b/3 Study

izokibep (ABY-035) - Affibody, ACELYRIN

Jacek Szepietowski1; Kim A. Papp2; Martina L Porter3; Seth Forman4; Howard L Sofen5; Amol Kamboj6; Paul Peloso6; Brian Wiens; Alexa B. Kimball3

May 24, 2023